Cargando…
PLCD1-Induced DNA Damage Inhibits the Tumor Growth via Downregulating CDKs in Chondrosarcoma
PURPOSE: Typical genes for the treatment and diagnosis of high-grade chondrosarcoma are still in need. Our study aimed to explore the PLCD1 function in chondrosarcoma for further treatment. MATERIALS AND METHODS: Our study collected the information of 49 patients in our department. The PLCD1 express...
Autores principales: | Shen, Jiakang, Yu, Chen, Wang, Zhuoying, Mu, Haoran, Cai, Zhengdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273466/ https://www.ncbi.nlm.nih.gov/pubmed/35836489 http://dx.doi.org/10.1155/2022/4488640 |
Ejemplares similares
-
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016) -
For cdks, one is enough
por: Leslie, Mitch
Publicado: (2007) -
Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma
por: Hu, Hai, et al.
Publicado: (2023) -
Cdks set the replication schedule
por: Leslie, Mitch
Publicado: (2010) -
Controlling DNA-end resection: a new task for CDKs
por: Ferretti, Lorenza P., et al.
Publicado: (2013)